199 related articles for article (PubMed ID: 19858003)
1. Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure.
Soubeyrand S; Pope L; Haché RJ
Mol Oncol; 2010 Feb; 4(1):38-51. PubMed ID: 19858003
[TBL] [Abstract][Full Text] [Related]
2. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
3. Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase.
Tanaka T; Halicka HD; Traganos F; Seiter K; Darzynkiewicz Z
Cell Cycle; 2007 Feb; 6(3):371-6. PubMed ID: 17297310
[TBL] [Abstract][Full Text] [Related]
4. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
5. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.
Montaudon D; Pourquier P; Denois F; de Tinguy-Moreaud E; Lagarde P; Robert J
Eur J Biochem; 1997 Apr; 245(2):307-15. PubMed ID: 9151958
[TBL] [Abstract][Full Text] [Related]
6. DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer.
Hansen LT; Lundin C; Helleday T; Poulsen HS; Sørensen CS; Petersen LN; Spang-Thomsen M
Lung Cancer; 2003 May; 40(2):157-64. PubMed ID: 12711116
[TBL] [Abstract][Full Text] [Related]
7. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.
Fan JR; Peng AL; Chen HC; Lo SC; Huang TH; Li TK
DNA Repair (Amst); 2008 Mar; 7(3):452-63. PubMed ID: 18206427
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
[TBL] [Abstract][Full Text] [Related]
10. Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.
Palmitelli M; de Campos-Nebel M; González-Cid M
Chromosome Res; 2015 Dec; 23(4):719-32. PubMed ID: 26152239
[TBL] [Abstract][Full Text] [Related]
11. A DNA repair player, ring finger protein 43, relieves etoposide-induced topoisomerase II poisoning.
Lerksuthirat T; Wikiniyadhanee R; Stitchantrakul W; Chitphuk S; Stansook N; Pipatpanyanugoon N; Jirawatnotai S; Dejsuphong D
Genes Cells; 2020 Nov; 25(11):718-729. PubMed ID: 32939879
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation.
Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732
[TBL] [Abstract][Full Text] [Related]
13. Etoposide quinone is a redox-dependent topoisomerase II poison.
Jacob DA; Mercer SL; Osheroff N; Deweese JE
Biochemistry; 2011 Jun; 50(25):5660-7. PubMed ID: 21595477
[TBL] [Abstract][Full Text] [Related]
14. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine.
Sorensen M; Sehested M; Jensen PB
Mol Pharmacol; 1999 Mar; 55(3):424-31. PubMed ID: 10051525
[TBL] [Abstract][Full Text] [Related]
15. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination.
de Campos-Nebel M; Larripa I; González-Cid M
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824055
[TBL] [Abstract][Full Text] [Related]
17. NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide.
Melo-Hanchuk TD; Slepicka PF; Pelegrini AL; Menck CFM; Kobarg J
J Cell Biochem; 2019 Oct; 120(10):16853-16866. PubMed ID: 31090963
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha.
Yan L; Bulgar A; Miao Y; Mahajan V; Donze JR; Gerson SL; Liu L
Clin Cancer Res; 2007 Mar; 13(5):1532-9. PubMed ID: 17332299
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin-induced G2 arrest and apoptosis in TK6 lymphoblastoid cells is not dependent on DNA double-strand break formation.
Smart DJ; Halicka HD; Traganos F; Darzynkiewicz Z; Williams GM
Cancer Biol Ther; 2008 Jan; 7(1):113-9. PubMed ID: 18059176
[TBL] [Abstract][Full Text] [Related]
20. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
